Answer:
According to Merck, the pharmaceutical company that manufactures Fosamax, osteoporosis is “a systemic disease characterized by low bone mass and microarchitectural deterioration of bone, with a consequent increase in bone fragility and susceptibility to fracture.” (2001) The problem with this definition is that a person with high bone density may fracture, while another with low bone density may never fracture. Low bone density is only one of many risk factors associated with osteoporosis. In fact, bone flexibility is more important than bone density, but it’s not as easy to measure.
Tags: bone density, bone flexibility, Merck, osteoporosis
